06:10 AM EDT, 06/10/2026 (MT Newswires) -- Ryan Preblick, Chief Financial Officer, on June 08, 2026, sold 36,000 shares in Indivior Pharmaceuticals ( INDV ) for $1,357,200. Following the Form 4 filing with the SEC, Preblick has control over a total of 284,751 common shares of the company, with 284,751 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1625297/000201486626000011/xslF345X05/wk-form4_1781085864.xml